Literature DB >> 22943877

Five-year trends in mortality indices among gynecological cancer patients in Canada.

Noori Akhtar-Danesh1, Alice Lytwyn, Laurie Elit.   

Abstract

OBJECTIVE: To estimate and compare the five-year trends in excess mortality rate, net probability of death, and crude probability of death for patients diagnosed with epithelial invasive gynecological cancers in Canada. We compared these trends among ovarian, uterine, and cervical cancers.
METHODS: A flexible parametric model was used to estimate the three mortality indices for gynecological cancers. We incorporated age group, type of cancer, and year of diagnosis in the model to estimate these indices over a five-year period after diagnosis.
RESULTS: In total, 39,681 women who were diagnosed with epithelial invasive gynecological cancers were included in this analysis with a mean age of 57.9 (SD=15.1) years at diagnosis. Approximately 30% of patients were younger than 50 years old at diagnosis and 45% were between 50 and 69 years old. Ovarian cancer had the worst prognosis among the gynecological cancers based on all three mortality indices.
CONCLUSIONS: The three mortality indices provide a clear insight in understanding the elements of mortality in population-based cancer studies where the underlying cause of death is not correctly identified, the accuracy of death certificates varies overtime and among countries, and death tends to be a multi-factorial event.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22943877     DOI: 10.1016/j.ygyno.2012.08.038

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Costs of cervical cancer treatment: population-based estimates from Ontario.

Authors:  C Pendrith; A Thind; G S Zaric; S Sarma
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

Review 2.  Optimal management of cervical cancer in HIV-positive patients: a systematic review.

Authors:  Atara Ntekim; Oladapo Campbell; Dietrich Rothenbacher
Journal:  Cancer Med       Date:  2015-07-01       Impact factor: 4.452

Review 3.  Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.

Authors:  Tae Hun Kim; Dong Hoon Suh; Mi-Kyung Kim; Yong Sang Song
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

4.  Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems.

Authors:  Norbert Stachowicz; Agata Smoleń; Michał Ciebiera; Tomasz Łoziński; Paweł Poziemski; Dariusz Borowski; Artur Czekierdowski
Journal:  Diagnostics (Basel)       Date:  2021-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.